10 NEWS
Biosynthetic Technologies acquires Innoleo
Indianapolis-based Biosynthetic Technologies, which makes synthetic compounds called estolides from organic fatty acids found in various bio-derived oils, has acquired Innoleo, a specialist in castor oil and derivatives located in Ohio. The products of both companies have applications in multiple industries, including personal care.
“The unique structure of
castor oil offers interesting properties, making it appropriate for various industrial applications,” said Mark Miller, CEO at Biosynthetic Technologies. In particular, he noted, it is high in ricinoleic acid, making it suitable in a wide variety of applications.
DKSH in two new deals
Switzerland’s DKSH has acquired the distribution business of Spanish firm HealthTech BioActives (HTBA), which produces and distributes flavours, ingredients, additives and intermediates to the food, pharmaceutical and personal care industries. This business has sales of about CHF 6 million/year. It will be fully integrated it into existing operations in Spain and Portugal. DKSH’s Performance Materials business unit has also extended an existing agreement with Elementis
and will now market Elementis’ entire range of speciality ingredients for personal care products, including antiperspirant actives, in Belgium. The two firms have been working together for 40 years and had previously extended this agreement into France in 2020.
Sytheon corrects THDC
Researchers at Sytheon, Sunny Biodiscovery and The Jewish Hospital in Cincinnati have published a paper in the International Journal of Molecular Sciences, clarifying the distinction between the ascorbic acid precursor tetrahexyldecyl ascorbate (THDC) and ascorbyl tetraisopalmitates. These had previously been
misnomer in journal Both are esters of ascorbic
acid, but THDC comes from a reaction with 2-hexyldecanoic acid while ascorbyl tetraisopalmitates are derived from a reaction with isopalmitic acid. Therefore, the researchers said, they are two different fatty acids that yield two products when esterified with ascorbic acid. Sytheon markets THDC under
Gattefossé launches ‘Escapism’ collection
Gattefossé is launching its new Inspiration 2022 collection. Named Escapism, this is described as “an invitation to dream of new destinations while rethinking the way of travelling” based on “practical and innovative formulas to accompany travellers in their new adventures”. The kit has five new
formulas, all in solid form for travel-friendliness and multi- functionality. They start with Magma Mask. This is a 98% natural origin mask in the form of solid black pellets, with one pellet representing a single dose so that only the amount needed is used. After crushing the pellet in the palm, the user mixes it with another of the formulas, Everything Balm, a multifunctional anhydrous balm texture, or just hot water.
PERSONAL CARE February 2022
This forms a thick black mask that is then spread directly onto the skin and rinsed off after ten minutes. Also in the collection are:
Softer Skin Stick, a scrub in a stick format for convenient use; Scalp & Body Scrub, an exfoliating wax that rinses easily; and Slide n’ Foam, a solid face cleanser with a new application process. “Each year, we focus on
one or more themes illustrated with new formulations. The idea is above all for our lab team members to let their imagination and creativity run free, to propose original and surprising formulas while respecting our charter in terms of naturality and sustainability,” said Flora Bollon, product marketing leader for texture and applications at Gattefossé.
regarded as being equivalent structures. However, they represent two different chemistries with different CAS numbers, according to the paper, which is entitled ‘Tetrahexyldecyl ascorbate (THDC) degrades rapidly under oxidative stress but can be stabilised by acetyl zingerone to enhance collagen production and antioxidant effects’.
the name VitaSynol C. It improves chemical stability and, because of its lipophilic nature, facilitates delivery into the epidermis and dermis, where it undergoes intracellular enzymatic conversion to free ascorbic acid. Indeed, free ascorbic acid must be released by THDC before its skin benefits can be realised. Thus, THDC is a precursor of ascorbic acid.
New lab for James Robinson
James Robinson Speciality Ingredients (JRSI) has launched a dedicated 186 m2
biotechnology
R&D facility called the Biotome division in Manchester, UK. The company is seeking to focus more on naturally derived products in its offer to the personal care market.
This follows a management
buyout of the James Robinson heritage brand for the part making ingredients for personal care and photochromics in 2019. The original firm had been based in Huddersfield since 1940 until being acquired by India’s Vivimed Labs in 2008.
www.personalcaremagazine.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
